drug acquisition
drug acquisition
Lonza Boosts US Manufacturing with $12B Acquisition!
🚀 Lonza has acquired Roche's Vacaville site for $1.2 billion, boosting U.S. manufacturing and investing $591 million for upgrades! 🏭✨
MilliporeSigma Boosts Gene Therapy with $600M Acquisition!
MilliporeSigma acquires Mirus Bio for $600 million, boosting viral vector manufacturing and supporting gene therapy advancements! 🚀🔬💡🤝
Repligen to Boost Bioprocessing with Tantti Acquisition!
**Excerpt:** 🌟 Repligen is set to acquire Tantti Laboratory, enhancing purification of biologics with innovative chromatography beads! 🧬📈 Exciting growth ahead! 🔜
Ligand Pharma Snaps Up Apeiron Biologics for $100M
📢 Ligand Pharma acquires Apeiron Biologics for $100M, invests $4M in invIOs Holding AG, and offers future event-based considerations. 🏢💰🏥🤝📅
MSD Snatches Eyebiotech Ltd for $3bn Dominates Vision Loss Market
💰 US pharma giant MSD acquires Eyebiotech Ltd for up to $3bn, gaining their clinical pipeline of vision loss candidates. 👁️🗨️🩺 Unanimously approved by EyeBio Board.
MilliporeSigma Acquires Mirus Bio for $600 Million Expanding in Gene Therapy Market
MilliporeSigma 💪 powers up with $600M acquisition of Mirus Bio! 📆 Closing in Q3 2024. 😮 CellAndGeneTherapy BiotechNews
Sino Biological Acquires SignalChem Biotech: Boosting Enzyme Expertise and Expanding Protein Presence!
📢 Sino Biological acquires SignalChem Biotech for $48 million, boosting their enzyme production and research capabilities. 🔬💰
Genmab’s $18bn Acquisition Boosts Cancer Pipeline
💥 Genmab is acquiring ProfoundBio for $1.8bn to expand its pipeline of antibody-drug conjugate therapies. 💊🏭🚀
Spanish Company Acquires ALS Treatment for €1225m
🇪🇸 Spanish Ferrer Internacional, SA pays €122.5m for ALS candidate, VRG50635, with promising Phase I trial results. 💰🧪
Novo Nordisk Acquires Cardior Pharmaceuticals for €1025bn Advancing Heart Failure Treatment
📢 Novo Nordisk acquires Cardior Pharmaceuticals for up to €1.025bn! ✨ Exciting Phase II trial for heart failure treatment! ⚙️💡
